Compile Data Set for Download or QSAR
maximum 50k data
Found 360 with Last Name = 'saunders' and Initial = 'md'
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242374(US10047093, 8-31 | US10392392, Example 8-31 | US10...)
Affinity DataIC50:  1nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242374(US10047093, 8-31 | US10392392, Example 8-31 | US10...)
Affinity DataIC50:  1nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242374(US10047093, 8-31 | US10392392, Example 8-31 | US10...)
Affinity DataIC50:  1nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242397(US10047093, 8-79 | US10392392, Example 8-79 | US10...)
Affinity DataIC50:  2nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242397(US10047093, 8-79 | US10392392, Example 8-79 | US10...)
Affinity DataIC50:  2nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242397(US10047093, 8-79 | US10392392, Example 8-79 | US10...)
Affinity DataIC50:  2nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242380(US10047093, 8-37 | US10392392, Example 8-37 | US10...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242388(US10047093, 8-68 | US10392392, Example 8-68 | US10...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242352(US10047093, 8-8 | US10392392, Example 8-8 | US1087...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242380(US10047093, 8-37 | US10392392, Example 8-37 | US10...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242388(US10047093, 8-68 | US10392392, Example 8-68 | US10...)
Affinity DataIC50:  4nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242352(US10047093, 8-8 | US10392392, Example 8-8 | US1087...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242352(US10047093, 8-8 | US10392392, Example 8-8 | US1087...)
Affinity DataIC50:  4nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242380(US10047093, 8-37 | US10392392, Example 8-37 | US10...)
Affinity DataIC50:  4nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242388(US10047093, 8-68 | US10392392, Example 8-68 | US10...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242372(US10047093, 8-29 | US10392392, Example 8-29 | US10...)
Affinity DataIC50:  5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043692(CHEMBL3355542 | US10047093, 8-52 | US10392392, Exa...)
Affinity DataIC50:  5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043692(CHEMBL3355542 | US10047093, 8-52 | US10392392, Exa...)
Affinity DataIC50:  5nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043692(CHEMBL3355542 | US10047093, 8-52 | US10392392, Exa...)
Affinity DataIC50:  5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242372(US10047093, 8-29 | US10392392, Example 8-29 | US10...)
Affinity DataIC50:  5nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242372(US10047093, 8-29 | US10392392, Example 8-29 | US10...)
Affinity DataIC50:  5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242378(US10047093, 8-35 | US10392392, Example 8-35 | US10...)
Affinity DataIC50:  7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242378(US10047093, 8-35 | US10392392, Example 8-35 | US10...)
Affinity DataIC50:  7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242348(US10047093, 8-4 | US10392392, Example 8-4 | US1087...)
Affinity DataIC50:  7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242348(US10047093, 8-4 | US10392392, Example 8-4 | US1087...)
Affinity DataIC50:  7nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242378(US10047093, 8-35 | US10392392, Example 8-35 | US10...)
Affinity DataIC50:  7nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242348(US10047093, 8-4 | US10392392, Example 8-4 | US1087...)
Affinity DataIC50:  7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM228294(US10047093, 8-11 | US10392392, Example 8-11 | US10...)
Affinity DataIC50:  8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM476631(US10875864, EX. 8-70)
Affinity DataIC50:  8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM228361(US10047093, 8-70 | US10392392, Example 8-70)
Affinity DataIC50:  8nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM228361(US10047093, 8-70 | US10392392, Example 8-70)
Affinity DataIC50:  8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM228294(US10047093, 8-11 | US10392392, Example 8-11 | US10...)
Affinity DataIC50:  8nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM228294(US10047093, 8-11 | US10392392, Example 8-11 | US10...)
Affinity DataIC50:  8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242354(US10047093, 8-10 | US10392392, Example 8-10 | US10...)
Affinity DataIC50:  9nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242354(US10047093, 8-10 | US10392392, Example 8-10 | US10...)
Affinity DataIC50:  9nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242354(US10047093, 8-10 | US10392392, Example 8-10 | US10...)
Affinity DataIC50:  9nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242351(US10047093, 8-7 | US10392392, Example 8-7 | US1087...)
Affinity DataIC50:  10nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242351(US10047093, 8-7 | US10392392, Example 8-7 | US1087...)
Affinity DataIC50:  10nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242351(US10047093, 8-7 | US10392392, Example 8-7 | US1087...)
Affinity DataIC50:  10nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242390(US10047093, 8-71 | US10392392, Example 8-71 | US10...)
Affinity DataIC50:  12nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242390(US10047093, 8-71 | US10392392, Example 8-71 | US10...)
Affinity DataIC50:  12nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242390(US10047093, 8-71 | US10392392, Example 8-71 | US10...)
Affinity DataIC50:  12nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242362(US10047093, 8-19 | US10392392, Example 8-19 | US10...)
Affinity DataIC50:  13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242353(US10047093, 8-9 | US10392392, Example 8-9 | US1087...)
Affinity DataIC50:  13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242362(US10047093, 8-19 | US10392392, Example 8-19 | US10...)
Affinity DataIC50:  13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242345(US10047093, 8-1 | US10392392, Example 8-1 | US1087...)
Affinity DataIC50:  13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242345(US10047093, 8-1 | US10392392, Example 8-1 | US1087...)
Affinity DataIC50:  13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242345(US10047093, 8-1 | US10392392, Example 8-1 | US1087...)
Affinity DataIC50:  13nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242353(US10047093, 8-9 | US10392392, Example 8-9 | US1087...)
Affinity DataIC50:  13nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242362(US10047093, 8-19 | US10392392, Example 8-19 | US10...)
Affinity DataIC50:  13nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 360 total ) | Next | Last >>
Jump to: